Citadel Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-706,331
| Closed | -$10.2M | – | 5974 |
|
|
2025
Q1 | $10.2M | Buy |
706,331
+81,015
| +13% | +$1.16M | ﹤0.01% | 1239 |
|
|
2024
Q4 | $10.5M | Buy |
625,316
+37,798
| +6% | +$633K | ﹤0.01% | 1299 |
|
|
2024
Q3 | $9.39M | Buy |
587,518
+549,242
| +1,435% | +$8.78M | ﹤0.01% | 1311 |
|
|
2024
Q2 | $346K | Sell |
38,276
-8,692
| -19% | -$78.5K | ﹤0.01% | 4178 |
|
|
2024
Q1 | $531K | Sell |
46,968
-53,836
| -53% | -$608K | ﹤0.01% | 3833 |
|
|
2023
Q4 | $802K | Buy |
100,804
+97,785
| +3,239% | +$778K | ﹤0.01% | 3255 |
|
|
2023
Q3 | $19.5K | Sell |
3,019
-1,086
| -26% | -$7.03K | ﹤0.01% | 5320 |
|
|
2023
Q2 | $25.4K | Buy |
+4,105
| New | +$25.4K | ﹤0.01% | 5198 |
|
|
2023
Q1 | – | Sell |
-72,307
| Closed | -$224K | – | 5992 |
|
|
2022
Q4 | $224K | Sell |
72,307
-153,061
| -68% | -$474K | ﹤0.01% | 4594 |
|
|
2022
Q3 | $906K | Sell |
225,368
-65,215
| -22% | -$262K | ﹤0.01% | 3508 |
|
|
2022
Q2 | $1.42M | Sell |
290,583
-13,843
| -5% | -$67.4K | ﹤0.01% | 3046 |
|
|
2022
Q1 | $2.73M | Sell |
304,426
-35,639
| -10% | -$320K | ﹤0.01% | 2670 |
|
|
2021
Q4 | $3.83M | Sell |
340,065
-9,483
| -3% | -$107K | ﹤0.01% | 2367 |
|
|
2021
Q3 | $5.84M | Sell |
349,548
-106,685
| -23% | -$1.78M | ﹤0.01% | 1914 |
|
|
2021
Q2 | $10.1M | Buy |
+456,233
| New | +$10.1M | ﹤0.01% | 1429 |
|